GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Athena Technology Acquisition Corp II (AMEX:ATEK) » Definitions » Valuation Rank

Athena Technology Acquisition II (Athena Technology Acquisition II) Valuation Rank


View and export this data going back to 2022. Start your Free Trial

What is Athena Technology Acquisition II Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Athena Technology Acquisition II Valuation Rank Related Terms

Thank you for viewing the detailed overview of Athena Technology Acquisition II's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Athena Technology Acquisition II (Athena Technology Acquisition II) Business Description

Traded in Other Exchanges
N/A
Address
442 5th Avenue, New York, NY, USA, 10018
Athena Technology Acquisition Corp II is a blank check company.
Executives
Trier Bryant director 2220 WESTCREEK LN 1404, HOUSTON TX 77027
Judith Rodin director C/O UNIVERSITY OF PENNSYLVANIA, 100 COLLEGE HALL, PHILADELPHIA PA 19104-6380
Sharon Brown-hruska director C/O MARKETAXESS HOLDINGS INC., 299 PARK AVENUE, NEW YORK NY 10171
Randi Zuckerberg director 394 PACIFIC AVE., SUITE 2, SAN FRANCISCO CA 94111
Kirthiga Reddy officer: President C/O PEAR THERAPEUTICS, INC., 200 STATE STREET, 13TH FLOOR, BOSTON MA 02109
Isabelle D. Freidheim director, 10 percent owner, officer: Chief Executive Officer 125 TOWNPARK DRIVE, SUITE 300, KENNESAW GA 30144
Athena Technology Sponsor Ii, Llc 10 percent owner 442 5TH AVENUE, NEW YORK NY 10018
Anna Apostolova officer: Chief Financial Officer C/O ATHENA TECHNOLOGY ACQUISITION CORP., 442 5TH AVENUE, NEW YORK NY 10018